1-3 of 3
Svein Skeie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial

Free
Hilde Smith-Strøm, Jannicke Igland, Truls Østbye, Grethe S. Tell, Marie F. Hausken, Marit Graue, Svein Skeie, John G. Cooper, Marjolein M. Iversen
Journal: Diabetes Care
Diabetes Care 2018;41(1):96–103
https://doi.org/10.2337/dc17-1025
Published: 29 November 2017
View articletitled, The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial
Open the PDF for The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial in another window
Includes: Supplementary data
Journal Articles

Six Months of Diazoxide Treatment at Bedtime in Newly Diagnosed Subjects With Type 1 Diabetes Does Not Influence Parameters of β-Cell Function and Autoimmunity but Improves Glycemic Control

Open Access
Maria Anita Radtke, MD, Ingrid Nermoen, MD, Magnus Kollind, PHD, Svein Skeie, PHD, Jan Inge Sørheim, MD, Johan Svartberg, PHD, Ingrid Hals, MSC, Torolf Moen, PHD, Gry Høst Dørflinger, MD, Valdemar Grill, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(3):589–594
https://doi.org/10.2337/dc09-1436
Published: 22 December 2009
View articletitled, Six Months of Diazoxide Treatment at Bedtime in Newly Diagnosed Subjects With Type 1 Diabetes Does Not Influence Parameters of β-Cell Function and Autoimmunity but Improves Glycemic Control
Open the PDF for Six Months of Diazoxide Treatment at Bedtime in Newly Diagnosed Subjects With Type 1 Diabetes Does Not Influence Parameters of β-Cell Function and Autoimmunity but Improves Glycemic Control in another window
Includes: Supplementary data
Journal Articles

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

Free
Philippe Vague, MD, PHD, Jean-Louis Selam, MD, Svein Skeie, MD, Ivo De Leeuw, Jan W.F. Elte, MD, PHD, Hanne Haahr, PHD, Allan Kristensen, MSC, Eberhard Draeger, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(3):590–596
https://doi.org/10.2337/diacare.26.3.590
Published: 01 March 2003
View articletitled, Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart
Open the PDF for Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart in another window